protein

Recombinant Human M-CSF Biotinylated Protein, CF

BT216-025

25 ug

828 USD

BT216

BT216-025

Recombinant Human M-CSF Biotinylated Protein, CF

25 ug

The Recombinant Human M-CSF Biotinylated Protein, CF from R&D Systems is derived from E. coli. The Recombinant Human M-CSF Biotinylated Protein, CF has been validated for the following applications: Bioactivity.

M-CSF

Proteins and Enzymes

Lyophilized from a 0.2 ╡m filtered solution in PBS with Trehalose.

Biotin

Bioactivity

>95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie« Blue Staining.

Human

15-22 kDa, under reducing conditions.

18.5 kDa

Measured by its binding ability in a functional ELISA. When Recombinant Human M-CSF R/CD115 Fc Chimera Protein (Catalog # 329-MR ) is immobilized at 0.5 ╡g/mL (100 ╡L/well), the concentration of Biotinylated Recombinant Human M-CSF (Catalog # BT216) that produces 50% of the optimal binding response is 1.50-15.0 ng/mL.

<0.10 EU per 1 ╡g of the protein by the LAL method.

NP_757350.2

Bioactivity

E. coli-derived Recombinant Human M-CSF Biotinylated Protein, CF

Biotinylated

828 USD

Biotinylated

colony stimulating factor 1 (macrophage), CSF1, CSF-1, Lanimostim, macrophage colony stimulating factor, macrophage colony-stimulating factor 1, MCSF, M-CSF, MCSFlanimostim, MGC31930

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 ░C as supplied. 1 month, 2 to 8 ░C under sterile conditions after reconstitution. 3 months, -20 to -70 ░C under sterile conditions after reconstitution.